Supernus Pharmaceuticals
Price & Volume
Stats
See moreOpen | $43.91 |
Previous Close | $44.19 |
Day Range | $43.14-$43.96 |
52W Range | $42.45-$59.68 |
Market Cap | $2.5B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $830.4M |
Revenue Growth (YoY) | 32.4% |
Gross Profit (12 Mos) | $605.3M |
Diluted EPS | -$1.90 |
News
See moreYahoo Finance • 3 days ago
Q2 Rundown: Pfizer (NYSE:PFE) Vs Other Branded Pharmaceuticals Stocks
Yahoo Finance • 8 days ago
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Corcept (NASDAQ:CORT)
Yahoo Finance • 11 days ago
1 Healthcare Stock with Exciting Potential and 2 We Ignore
Yahoo Finance • 25 days ago
Supernus and Indivior merge to create scaled, CNS-focused entity
About
CEO | Mr. Jack A. Khattar M.B.A. |
CFO | Mr. Timothy C. Dec |
Address | 9715 Key West Avenue, Rockville, MD, United States, 20850 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 778 |